Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Sibbing

Showing results (91-100 of 200) with videos related to

Pageof 20
Sort By:
Clinical Cardiology|August 29, 2024
Clopidogrel Versus Aspirin as Monotherapy Following Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome Receiving a Drug-Eluting Stent: A Systematic Literature Review and Meta-AnalysisDirk Sibbing, Johny Nicolas, Alessandro Spirito, et al.
European Heart Journal|February 6, 2009
Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary interventionDirk Sibbing, Julia Stegherr, Wolfgang Latz, et al.
International Journal of Cardiology|June 19, 2012
Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysisDániel Aradi, András Komócsi, Matthew J Price, et al.
European Heart Journal|February 18, 2010
Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrelDirk Sibbing, Nicolas von Beckerath, Tanja Morath, et al.
European Heart Journal|April 30, 2011
No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stentingDirk Sibbing, Werner Koch, Steffen Massberg, et al.
Platelets|June 9, 2016
Ticagrelor versus prasugrel in patients with high on-clopidogrel treatment platelet reactivity after PCI: The ISAR-ADAPT-PF studyIsabell Bernlochner, Katharina Mayer, Martin Orban, et al.
JACC. Cardiovascular Interventions|March 7, 2020
Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel: The ABCD-GENE ScoreDominick J Angiolillo, Davide Capodanno, Nicolas Danchin, et al.
Circulation|January 20, 2010
Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placementDirk Sibbing, Werner Koch, Daniela Gebhard, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 4, 2023
Impact of body mass on P2Y12-inhibitor de-escalation in acute coronary syndromes-a substudy of the TROPICAL-ACS trialAndrás Komócsi, Béla Merkely, Martin Hadamitzky, et al.
Thrombosis Research|December 8, 2015
Platelet function and coagulation in patients with STEMI and peri-interventional clopidogrel plus heparin vs. prasugrel plus bivalirudin therapy (BRAVE 4 substudy)Daniel Braun, Antonia Knipper, Martin Orban, et al.
Pageof 20

Showing results (91-100 of 200) with videos related to

Sort By:
Pageof 20
Clinical Cardiology|August 29, 2024
Clopidogrel Versus Aspirin as Monotherapy Following Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome Receiving a Drug-Eluting Stent: A Systematic Literature Review and Meta-AnalysisDirk Sibbing, Johny Nicolas, Alessandro Spirito, et al.
European Heart Journal|February 6, 2009
Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary interventionDirk Sibbing, Julia Stegherr, Wolfgang Latz, et al.
International Journal of Cardiology|June 19, 2012
Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysisDániel Aradi, András Komócsi, Matthew J Price, et al.
European Heart Journal|February 18, 2010
Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrelDirk Sibbing, Nicolas von Beckerath, Tanja Morath, et al.
European Heart Journal|April 30, 2011
No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stentingDirk Sibbing, Werner Koch, Steffen Massberg, et al.
Platelets|June 9, 2016
Ticagrelor versus prasugrel in patients with high on-clopidogrel treatment platelet reactivity after PCI: The ISAR-ADAPT-PF studyIsabell Bernlochner, Katharina Mayer, Martin Orban, et al.
JACC. Cardiovascular Interventions|March 7, 2020
Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel: The ABCD-GENE ScoreDominick J Angiolillo, Davide Capodanno, Nicolas Danchin, et al.
Circulation|January 20, 2010
Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placementDirk Sibbing, Werner Koch, Daniela Gebhard, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 4, 2023
Impact of body mass on P2Y12-inhibitor de-escalation in acute coronary syndromes-a substudy of the TROPICAL-ACS trialAndrás Komócsi, Béla Merkely, Martin Hadamitzky, et al.
Thrombosis Research|December 8, 2015
Platelet function and coagulation in patients with STEMI and peri-interventional clopidogrel plus heparin vs. prasugrel plus bivalirudin therapy (BRAVE 4 substudy)Daniel Braun, Antonia Knipper, Martin Orban, et al.
Pageof 20